» Articles » PMID: 33301503

CD8 T Cell Epitope Generation Toward the Continually Mutating SARS-CoV-2 Spike Protein in Genetically Diverse Human Population: Implications for Disease Control and Prevention

Overview
Journal PLoS One
Date 2020 Dec 10
PMID 33301503
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The ongoing pandemic of SARS-CoV-2 has brought tremendous crisis on global health care systems and industrial operations that dramatically affect the economic and social life of numerous individuals worldwide. Understanding anti-SARS-CoV-2 immune responses in population with different genetic backgrounds and tracking the viral evolution are crucial for successful vaccine design. In this study, we reported the generation of CD8 T cell epitopes by a total of 80 alleles of three major class I HLAs using NetMHC 4.0 algorithm for the SARS-CoV-2 spike protein, which can be targeted by both B cells and T cells. We found diverse capacities of S protein specific epitope presentation by different HLA alleles with very limited number of predicted epitopes for HLA-B*2705, HLA-B*4402 and HLA-B*4403 and as high as 132 epitopes for HLA-A*6601. Our analysis of 1000 S protein sequences from field isolates collected globally over the past few months identified three recurrent point mutations including L5F, D614G and G1124V. Differential effects of these mutations on CD8 T cell epitope generation by corresponding HLA alleles were observed. Finally, our multiple alignment analysis indicated the absence of seasonal CoV induced cross-reactive CD8 T cells to drive these mutations. Our findings suggested that individuals with certain HLA alleles, such as B*44 are more prone to SARS-CoV-2 infection. Studying anti-S protein specific CD8 T cell immunity in diverse genetic background is critical for better control and prevention of the SARS-CoV-2 pandemic.

Citing Articles

HLA-B27 did not protect against COVID-19 in patients with axial spondyloarthritis - data from the ReumaCov-Brasil Registry.

Mota G, Marques C, Ribeiro S, Albuquerque C, Castro G, Fernandino D Adv Rheumatol. 2023; 63(1):56.

PMID: 38031143 DOI: 10.1186/s42358-023-00340-0.


Characterization of SARS-CoV-2 Variants in Military and Civilian Personnel of an Air Force Airport during Three Pandemic Waves in Italy.

Equestre M, Marcantonio C, Marascio N, Centofanti F, Martina A, Simeoni M Microorganisms. 2023; 11(11).

PMID: 38004723 PMC: 10672769. DOI: 10.3390/microorganisms11112711.


CD8 T-cell immune escape by SARS-CoV-2 variants of concern.

Kombe Kombe A, Biteghe F, Ndoutoume Z, Jin T Front Immunol. 2022; 13:962079.

PMID: 36389664 PMC: 9647062. DOI: 10.3389/fimmu.2022.962079.


RG203KR Mutations in SARS-CoV-2 Nucleocapsid: Assessing the Impact Using a Virus-Like Particle Model System.

Raheja H, Das S, Banerjee A, P D, C D, Mukhopadhyay D Microbiol Spectr. 2022; 10(4):e0078122.

PMID: 35862952 PMC: 9430728. DOI: 10.1128/spectrum.00781-22.


Spike Mutation Profiles Associated With SARS-CoV-2 Breakthrough Infections in Delta Emerging and Predominant Time Periods in British Columbia, Canada.

Fibke C, Joffres Y, Tyson J, Colijn C, Janjua N, Fjell C Front Public Health. 2022; 10:915363.

PMID: 35859775 PMC: 9289444. DOI: 10.3389/fpubh.2022.915363.


References
1.
Wang M, Li M, Ren R, Li L, Chen E, Li W . International Expansion of a Novel SARS-CoV-2 Mutant. J Virol. 2020; 94(12). PMC: 7307084. DOI: 10.1128/JVI.00567-20. View

2.
Sun X, Shi Y, Akahoshi T, Fujiwara M, Gatanaga H, Schonbach C . Effects of a Single Escape Mutation on T Cell and HIV-1 Co-adaptation. Cell Rep. 2016; 15(10):2279-2291. DOI: 10.1016/j.celrep.2016.05.017. View

3.
Korber B, Fischer W, Gnanakaran S, Yoon H, Theiler J, Abfalterer W . Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus. Cell. 2020; 182(4):812-827.e19. PMC: 7332439. DOI: 10.1016/j.cell.2020.06.043. View

4.
Berkhoff E, Boon A, Nieuwkoop N, Fouchier R, Sintnicolaas K, Osterhaus A . A mutation in the HLA-B*2705-restricted NP383-391 epitope affects the human influenza A virus-specific cytotoxic T-lymphocyte response in vitro. J Virol. 2004; 78(10):5216-22. PMC: 400375. DOI: 10.1128/jvi.78.10.5216-5222.2004. View

5.
Lv Y, Ruan Z, Wang L, Ni B, Wu Y . Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV. BMC Immunol. 2009; 10:61. PMC: 2792222. DOI: 10.1186/1471-2172-10-61. View